Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 abril 2013

JACC: CARDIOVASCULAR INTERVENTIONS. Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke.The ReFlow (Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke) Study

Christian Roth, MD; Wolfgang Reith, MD; Silke Walter, MD; Stefanie Behnke, MD; Michael Kettner, MD; Julio Viera, MD; Umut Yilmaz, MD; Maria Alexandrou, MD; Maria Politi, MD; Panagiotis Kostopoulos, MD; Heiko Körner, MD; Christoph Krick, MD; Anton Haass, MD; Klaus Fassbender, MD; Panagiotis Papanagiotou, MD

Objectives: This study sought to assess the feasibility and safety of a recently described technique of mechanical recanalization with the help of a stent-like device.

01 mayo 2012

STROKE. Clinical Prediction Rule to Estimate the Absolute 3-Year Risk of Major Cardiovascular Events After Carotid Endarterectomy

Guus W. van Lammeren, MD; Louise M. Catanzariti, MSc; Linda M. Peelen, PhD; Jean-Paul P.M. de Vries, MD, PhD; Dominique P.V. de Kleijn, PhD; Frans L. Moll, MD, PhD; Gerard Pasterkamp, MD, PhD; Michiel L. Bots, MD, PhD

Background and Purpose—Prognosis after carotid endarterectomy is mainly determined by the occurrence of major adverse cardiovascular events (MACEs). Optimal medical treatment to reduce risk is the mainstay of MACE prevention. The level of risk of MACE may determine the initiation and aggressiveness of medical treatment, yet a prediction rule to assess that absolute MACE risk after carotid endarterectomy is currently unavailable.

01 mayo 2012

JACC. First In Vivo Application of Microwave Radiometry in Human Carotids. A New Noninvasive Method for Detection of Local Inflammatory Activation

Konstantinos Toutouzas, MD; Charalampos Grassos, MD; Maria Drakopoulou, MD; Andreas Synetos, MD; Eleftherios Tsiamis, MD; Constantina Aggeli, MD; Konstantinos Stathogiannis, MD; Dimitrios Klettas, MD; Nikolaos Kavantzas, MD; Georgios Agrogiannis, MD; Efstratios Patsouris, MD; Christos Klonaris, MD; Nikolaos Liasis, MD; Dimitrios Tousoulis, MD; Elias Siores, BSc, MSc, PhD; Christodoulos Stefanadis, MD

Objectives: This study investigated whether temperature differences: 1) can be measured in vivo noninvasively by microwave radiometry (MR); and 2) are associated with ultrasound and histological findings.

01 abril 2013

JACC: CARDIOVASCULAR INTERVENTIONS. Impact of Asymptomatic Cerebral Lesions in Diffusion-Weighted Magnetic Resonance Imaging After Carotid Artery Stenting

Klaudija Bijuklic, MD; Andreas Wandler, MD; Thilo Tübler, MD; Joachim Schofer, MD, PhD

Objectives: This study sought to analyze the impact of new asymptomatic cerebral ischemic lesions, found in diffusion-weighted magnetic resonance imaging (DW-MRI) after carotid artery stenting (CAS) in relation to other risk factors for major adverse cerebral and cardiovascular events (MACCE) defined as death, stroke, and myocardial infarction.

01 abril 2013

JACC. Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting. Results of the Randomized ARMYDA-9 CAROTID Study

Giuseppe Patti, MD; Fabrizio Tomai, MD; Rosetta Melfi, MD; Elisabetta Ricottini, MD; Michele Macrì, MD; Pietro Sedati, MD; Arianna Giardina, MD; Cristina Aurigemma, MD; Mario Leporace, MD; Andrea D Ambrosio, MD; Germano Di Sciascio, MD

Objectives This study sought to evaluate whether a strategy with a 600-mg clopidogrel load and a short-term, high-dose atorvastatin reload would improve outcomes in clopidogrel-naïve, statin-treated patients undergoing protected carotid stenting.

06 febrero 2013

JACC. Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial FibrillationAnalysis From the ROCKET AF Trial

Manesh R. Patel, MD; Anne S. Hellkamp, MS; Yuliya Lokhnygina, PhD; Jonathan P. Piccini, MD; Zhongxin Zhang, PhD; Surya Mohanty, PhD; Daniel E. Singer, MD; Werner Hacke, MD, PhD; Günter Breithardt, MD; Jonathan L. Halperin, MD; Graeme J. Hankey, MD; Richard C. Becker, MD; Christopher C. Nessel, MD; Scott D. Berkowitz, MD; Robert M. Califf, MD; Keith A.A. Fox, MB, ChB; Kenneth W. Mahaffey, MD

Objectives The purpose of this study was to understand the possible risk of discontinuation in the context of clinical care.

01 marzo 2013

EUROPEAN HEART JOURNAL. Stroke and coronary heart disease: predictive power of standard risk factors into old age—long-term cumulative risk study among men in Gothenburg, Sweden

Kok Wai Giang, Lena Björck, Masuma Novak, Georgios Lappas, Lars Wilhelmsen, Kjell Torén and Annika Rosengren

Aims: The aim of this study was to examine the short-term and long-term cumulative risk of coronary heart disease (CHD) and stroke separately based on age, sex, smoking status, systolic blood pressure, and total serum cholesterol.

28 septiembre 2012

WORLD JOURNAL OF RADIOLOGY. Endovascular treatment of extracranial vertebral artery stenosis

Burak Kocak, Bora Korkmazer, Civan Islak, Naci Kocer and Osman Kizilkilic.

Percutaneous angioplasty and stenting for the treatment of extracranial vertebral artery (VA) stenosis seems a safe, effective and useful technique for resolving symptoms and improving blood flow to the posterior circulation, with a low complication rate and good long-term results. In patients with severe tortuosity of the vessel, stent placement is a real challenge. The new coronary balloon-expandable stents may be preferred. A large variability of restenosis rates has been reported. Drug-eluting stents may be the solution. After a comprehensive review of the literature, it can be concluded that percutaneous angioplasty and stenting of extracranial VA stenosis is technically feasible, but there is insufficient evidence from randomized trials to demonstrate that endovascular management is superior to best medical management.

01 febrero 2012

EUROPEAN HEART JOURNAL. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation

Ulf Landmesser and David R. Holmes Jr

Atrial fibrillation is a frequent cause of stroke; in the elderly, more than 20% of strokes are attributed to this common arrhythmia. Anticoagulation with warfarin reduces the risk of stroke by ∼60%; however, a large proportion of patients with atrial fibrillation do not receive this treatment because of relative/absolute contraindications. Moreover, patients often discontinue warfarin for a variety of reasons and chronic warfarin administration rates remain suboptimal. Although the compliance with anticoagulation may improve with novel anticoagulants and bleeding risk can be somewhat reduced when compared with warfarin, there is still a progressive increase in bleeding complications over time. Accordingly, new approaches for stroke prevention in these patients are being explored and tested. In transoesophageal echocardiographic (TEE) studies, more than 90% of thrombi were found in the left atrial appendage (LAA) in non-valvular atrial fibrillation, and transcatheter LAA closure is developed and examined as a novel approach to reduce the risk of stroke in these patients. The PROTECT-AF study provides first evidence from a randomized clinical trial that a strategy of LAA occlusion using the Watchman device can be non-inferior to anticoagulation with warfarin for a combined endpoint in patients with non-valvular atrial fibrillation (mean CHADS2 score 1.8). In successfully occluded patients fulfilling TEE criteria (86%), warfarin was stopped after 45 days, followed by aspirin and clopidogrel for 6 months after randomization and subsequently aspirin. The PREVAIL trial is further evaluating this concept. Limited data are available for another LAA occlusion system, the Amplatzer Cardiac Plug (ACP) device, for which the ACP trial has been initiated. Left atrial appendage occlusion needs to be performed with meticulous care by experienced operators because periprocedural complications such as pericardial effusion or stroke have been documented. With increased operator experience and technical improvements of the device, these complications can be minimized.

01 diciembre 2012

JOURNAL OF CEREBROVASCULAR AND ENDOVASCULAR NEUROSURGERY. Intracranial Aneurysm Following Cranial Radiation Therapy

Won Huh, MD, Jae Seung Bang, MD, Chang Wan Oh, MD, PhD, O-Ki Kwon, MD, PhD, Gyojun Hwang, MD

We report herein a case of a radiation-induced aneurysm. A 69-year-old woman presented with subarachnoid hemorrhage. Eight years previously, she had undergone cranial radiation therapy (total dose of 59.4 Gy) as adjuvant therapy after surgical resection for a chondrosarcoma that was destroying her sphenoid sinus. The patient underwent catheter angiography, which revealed an aneurysm of the anterior communicating artery and luminal narrowing and irregularity in the petrous and lacerum segments of the right internal carotid artery. We attempted surgical clipping of the aneurysm, but there was repeated bleeding. Finally the aneurysm was treated with endovascular trapping. Potentially fatal bleeding also occurred from her internal carotid artery, which had also been irradiated during the previous cranial radiation therapy. We stopped the bleeding with endovascular coil embolization. Because of diffuse vascular changes of the cerebral vessels within irradiated fields, special attention must be paid to their treatment.

01 marzo 2012

STROKE. Stenting Versus Surgery in Patients With Carotid Stenosis After Previous Cervical Radiation Therapy

Margriet Fokkema, MSc; Anne G. den Hartog, MD; Michiel L. Bots, MD, PhD; Ingeborg van der Tweel, PhD; Frans L. Moll, MD, PhD; Gert Jan de Borst, MD, PhD

Background and Purpose—Patients with both carotid stenosis and previously cervical radiation therapy are considered “high risk” for carotid endarterectomy (CEA). Carotid angioplasty and stenting (CAS) seems a reasonable alternative, but neither the operative risk for CEA nor the effectiveness of CAS has been proven. The purpose of this study was to evaluate perioperative and long-term outcome of both procedures in patients with radiation therapy.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.